About
- Company
- History
- Team
Expertise
- R&D Lab
- Formulations
- Device
- Resources
- FAQ
Press
Investors
Kanabo.store
Treat It
GP Service
Contact

Kanabo Group Appoints Ian Mattioli as Chair of the Board and Secures a £2.5M Minimum Investment Round

Posts navigation

Overview

Kanabo is creating a new standard in the medical cannabis industry by building a holistic ecosystem that works together in synergy to improve the well-being of millions around the world. We focus on the distribution of cannabis-derived products for medical patients, and non-THC products for CBD consumers. We have conducted extensive R&D in order to develop high-quality cannabis oil formulas, innovative medical-grade vaporizers, and various non-smoking consumption solutions – making use easy and accessible for anyone in need of treatment. Clinical and validation activities, including safety and efficiency tests, are conducted in Israel – an established leader in the cannabis industry.
The company is selling initial products in Europe already, and is ready to scale up to meet market demands and projected sales and revenues.

Contact

Kanabo Research LTD

HaBarzel St. 21a
Tel Aviv 6971029
Israel

Churchill House
137-139 Brent Street
London NW4 4DJ
United Kingdom

Follow

Contact
Press
Privacy Policy

© Kanabo LTD All rights reserved 2024